Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -8.639% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) CC1(C)C(C(=O)NCc2ccco2)C1(C)C
(b) c1ccc2c3n(nc2c1)CCCO3
(c) O=C(CSc1nccn1-c1ccc(F)cc1)Nc1ccc2c(c1)OCO2
Answer: c. O=C(CSc1nccn1-c1ccc(F)cc1)Nc1ccc2c(c1)OCO2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CSc1nccn1-c1ccc(F)cc1)Nc1ccc2c(c1)OCO2
O=C(CSc1nccn1-c1ccc(F)cc1)Nc1ccc2c(c1)OCO2
N-(1,3-benzodioxol-5-yl)-2-[1-(4-fluorophenyl)imidazol-2-yl]sulfanylacetamide